Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedOct 13, 2024
DataAggregated Company Financials
Companies7
  • 7D-0.4%
  • 3M-1.5%
  • 1Y20.9%
  • YTD34.0%

In the last week, Life Sciences has been flat. The past year has been better, since the industry has gained 21% in that time. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 13 Oct 2024CHF 54.1bCHF 10.2bCHF 943.5m41.4x57.4x5.3x
Tue, 10 Sep 2024CHF 56.4bCHF 10.2bCHF 937.1m44.2x60.2x5.5x
Thu, 08 Aug 2024CHF 57.7bCHF 10.2bCHF 924.1m44.7x62.4x5.6x
Sat, 06 Jul 2024CHF 54.3bCHF 10.3bCHF 1.0b46.3x54.2x5.3x
Mon, 03 Jun 2024CHF 52.2bCHF 10.3bCHF 1.0b43.9x52.1x5.1x
Wed, 01 May 2024CHF 53.8bCHF 10.3bCHF 1.0b43.6x53.7x5.2x
Fri, 29 Mar 2024CHF 58.5bCHF 10.3bCHF 1.0b47x58.3x5.7x
Sun, 25 Feb 2024CHF 50.6bCHF 10.2bCHF 982.3m47.1x51.5x5x
Tue, 23 Jan 2024CHF 42.3bCHF 9.8bCHF 1.5b31.3x28.3x4.3x
Thu, 21 Dec 2023CHF 41.1bCHF 9.8bCHF 1.5b32.2x27.5x4.2x
Sat, 18 Nov 2023CHF 41.5bCHF 9.8bCHF 1.5b29.5x27.8x4.2x
Mon, 16 Oct 2023CHF 45.6bCHF 9.8bCHF 1.5b30.4x30.5x4.7x
Wed, 13 Sep 2023CHF 51.7bCHF 9.8bCHF 1.5b35x34.7x5.3x
Fri, 11 Aug 2023CHF 53.6bCHF 9.8bCHF 1.5b35.9x34.6x5.5x
Sun, 09 Jul 2023CHF 54.6bCHF 9.7bCHF 1.6b35.7x33.4x5.6x
Tue, 06 Jun 2023CHF 60.1bCHF 9.7bCHF 1.6b37.1x36.8x6.2x
Thu, 04 May 2023CHF 61.2bCHF 9.7bCHF 1.6b41.3x37.4x6.3x
Sat, 01 Apr 2023CHF 58.1bCHF 9.7bCHF 1.7b42x34.8x6x
Mon, 27 Feb 2023CHF 58.9bCHF 9.6bCHF 1.7b34.6x35.4x6.2x
Wed, 25 Jan 2023CHF 52.6bCHF 9.2bCHF 1.3b39.6x39.6x5.7x
Fri, 23 Dec 2022CHF 49.5bCHF 9.2bCHF 1.3b36.7x37.3x5.4x
Sun, 20 Nov 2022CHF 53.3bCHF 9.2bCHF 1.3b40.4x40.1x5.8x
Tue, 18 Oct 2022CHF 51.3bCHF 9.2bCHF 1.3b40.4x38.6x5.6x
Thu, 15 Sep 2022CHF 51.6bCHF 9.2bCHF 1.3b40.8x39.9x5.6x
Sat, 13 Aug 2022CHF 57.7bCHF 8.9bCHF 1.3b36.1x44x6.5x
Mon, 11 Jul 2022CHF 58.1bCHF 8.5bCHF 1.1b45.1x53.9x6.9x
Wed, 08 Jun 2022CHF 58.5bCHF 8.5bCHF 1.1b48.4x54.2x6.9x
Fri, 06 May 2022CHF 56.2bCHF 8.5bCHF 1.1b32.3x52x6.6x
Sun, 03 Apr 2022CHF 69.6bCHF 8.3bCHF 1.1b51.3x64.5x8.4x
Tue, 01 Mar 2022CHF 67.8bCHF 8.0bCHF 1.1b54.1x63.5x8.5x
Thu, 27 Jan 2022CHF 66.0bCHF 7.4bCHF 929.3m69.1x71x8.9x
Sat, 25 Dec 2021CHF 82.5bCHF 7.4bCHF 929.3m93.5x88.8x11.2x
Mon, 22 Nov 2021CHF 81.2bCHF 7.4bCHF 918.5m74.1x88.4x11x
Wed, 20 Oct 2021CHF 78.6bCHF 7.4bCHF 919.7m76.1x85.5x10.7x
Price to Earnings Ratio

85.5x


Total Market Cap: CHF 78.6bTotal Earnings: CHF 919.7mTotal Revenue: CHF 7.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 48.3x202220232024
Current Industry PE
  • Investors are optimistic on the Swiss Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 57.4x which is higher than its 3-year average PE of 48.4x.
  • The 3-year average PS ratio of 6.2x is higher than the industry's current PS ratio of 5.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market1.04%
Healthcare1.92%
Life Sciences-0.42%
Clinical Research and Equipment-0.42%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SFZN Siegfried HoldingCHF 1.15k1.2%
+CHF 60.1m		59.1%PE38.3x
LONN Lonza GroupCHF 525.200.04%
+CHF 14.4m		25.6%PE66.2x
SKAN SKAN GroupCHF 78.400.6%
+CHF 11.2m		6.2%PE54.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

LONN

CHF 525.20

Lonza Group

7D

0.04%

1Y

25.6%

TECN

CHF 264.80

Tecan Group

7D

-2.9%

1Y

-6.3%

Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable

Oct 09
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable

SKAN

CHF 78.40

SKAN Group

7D

0.6%

1Y

6.2%

Should You Investigate SKAN Group AG (VTX:SKAN) At CHF77.10?

Oct 08
Should You Investigate SKAN Group AG (VTX:SKAN) At CHF77.10?

XLS

CHF 25.00

Xlife Sciences

7D

-8.4%

1Y

-36.1%

BANB

CHF 67.45

Bachem Holding

7D

-2.7%

1Y

-5.9%

Bachem Holding AG's (VTX:BANB) P/E Still Appears To Be Reasonable

Sep 29
Bachem Holding AG's (VTX:BANB) P/E Still Appears To Be Reasonable

PPGN

CHF 27.00

PolyPeptide Group

7D

-6.1%

1Y

54.3%

Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)

Sep 16
Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)

SFZN

CHF 1,152.00

Siegfried Holding

7D

1.2%

1Y

59.1%

Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?

Sep 12
Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?